Nwabudike Lawrence Chukwudi
Outpatient Dermatology Department, N. Paulescu National Institute of Diabetes, Bucharest, Romania.
Homeopathy. 2019 Nov;108(4):277-284. doi: 10.1055/s-0039-1687822. Epub 2019 Jul 25.
Mycosis fungoides (MF) is an uncommon, indolent, form of cutaneous T cell lymphoma, of which there are various types according to international classification. Various treatment modalities are available; however, these are fraught with potentially severe adverse effects.
Three cases of immunohistochemically confirmed MF were treated with classical individualized homeopathy. Each case was followed up with photographic documentation and was reported according to the criteria set out in the HOM-CASE guidelines. Based on the WHO-EORTC (World Health Organization-European Organization for Research and Treatment of Cancer) criteria, the patients were classified as T1b, T1a/T1b and T2b respectively.
All cases remitted following homeopathic treatment and remained in remission. Side effects were not reported in these cases.
MF may respond to individualized homeopathic medicine. Although the case number here is small, MF is not a common disorder, spontaneous remission is not usually expected, and the disease may progress to a more severe form. Hence, these findings could serve as a basis for further research into the role of individualized homeopathic medicine in the treatment of MF.
蕈样肉芽肿（MF）是一种罕见的、惰性的皮肤T细胞淋巴瘤，根据国际分类有多种类型。有多种治疗方式可供选择；然而，这些治疗方式都存在潜在的严重不良反应。
3例经免疫组化确诊的MF患者接受了经典的个体化顺势疗法治疗。每例患者均通过拍照记录进行随访，并根据HOM-CASE指南规定的标准进行报告。根据世界卫生组织-欧洲癌症研究与治疗组织（WHO-EORTC）标准，这3例患者分别被归类为T1b、T1a/T1b和T2b。
所有病例在接受顺势疗法治疗后均缓解并持续处于缓解状态。这些病例均未报告有副作用。
MF可能对个体化顺势疗法有反应。尽管此处病例数量较少，但MF并非常见疾病，通常不期望出现自发缓解，且该疾病可能进展为更严重的形式。因此，这些发现可为进一步研究个体化顺势疗法在MF治疗中的作用提供依据。
